Skip to content

Analysis of pathogenic mechanism of colorectal sessile serrated adenoma/polyp and hyperplastic polyp : clarification of molecular basis by gene expression profiling

Analysis of pathogenic mechanism of colorectal sessile serrated adenoma/polyp and hyperplastic polyp : clarification of molecular basis by gene expression profiling - Gene expression profiling of colorectal sessile serrated adenoma/polyp and hyperplastic polyp

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000027365
Enrollment
20
Registered
2017-06-01
Start date
2017-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal sessile serrated adenoma/polyp (SSA/P) and colorectal hyperplastic polyp (HP)

Interventions

None listed

Sponsors

The University of Tokyo Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All cases which were diagnosed as sessile serrated adenoma/polyp or hyperplastic polyp by endoscopy or histopathologic examination.

Exclusion criteria

Exclusion criteria: Cases such as medical history of surgical removal of colorectal, duplicated malignant disease, familial adenomatous polyposis, inflammatory bowel disease, minor/elderly person/handicapped person who is needed special consideration, cases which were not diagnosed as sessile serrated adenoma or hyperplastic polyp.

Design outcomes

Primary

MeasureTime frame
gene expression profiling and genetic analyses of SSA/P and HP

Countries

Japan

Contacts

Public ContactDaisuke Oki

The University of Tokyo Hospital Department of Gastroenterology, Graduate School of Medicine

daisuke-oki@umin.ac.jp03-3815-5411ext.34718

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026